Calla Health Foundation is a Duke University spin off company that seeks to commercialize and successfully bring to market intellectual property developed at Duke University and, more specifically, the Center for Global Women’s Health Technologies (GWHT). We see development of products from concept through to clinical use and, ultimately, market entry.
Located within the Chesterfield Building of downtown Durham, NC, Calla Health employs four employees who collectively lead product manufacturing, automated algorithms and software, and generate evidence through clinical implementation. Our core competencies include optical imaging system design, rapid prototyping, machine learning diagnostic algorithms, software development, mechanical and electrical engineering, clinical study design, and regulatory clearance.
Calla Health Foundation is a Duke University spin off company that seeks to commercialize and successfully bring to market intellectual property developed at Duke University and, more specifically, the Center for Global Women’s Health Technologies (GWHT). We see development of products from concept through to clinical use and, ultimately, market entry.
Located within the Chesterfield Building of downtown Durham, NC, Calla Health employs four employees who collectively lead product manufacturing, automated algorithms and software, and generate evidence through clinical implementation.
Read more about our mission >>Art exhibit to create awareness for cervical cancer and reproduction of the Callascope
Our time educating & spreading awareness in Ghana
Midwife at La Liga Contra El Cancer Mobile Clinic testing out the Pocket Colposcope
Art exhibit to create awareness for cervical cancer and reproduction of the Callascope
Our time educating & spreading awareness in Ghana
Team visits a Mobile cervical cancer screening van in Lima, Peru
Cervical cancer is the second leading cause of death for women worldwide; 85% of deaths occur in low and middle-income countries (LMICs), despite the fact that well-established interventions exist for pre-invasive disease. Many low-resource countries lack the health care infrastructure required for the cytology-based screening and referral colposcopic diagnosis that have dramatically reduced the disease burden in wealthier countries.
meet our team >>